EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance study

Mahan Ghafari, Steven A Kemp, Matthew Hall, Joseph Clarke, Luca Ferretti, Laura Thomson, Ruth Studley, COVID-19 Infection Survey Group, COVID-19 Genomics UK (COG-UK) Consortium, Ann Sarah Walker, Tanya Golubchik, Katrina Lythgoe

The Lancet Microbe · 2025-09 · 6 (9) · 101154

DOI: 10.1016/j.lanmic.2025.101154 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift The Lancet Microbe, 2025-09. Verfasst von Mahan Ghafari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pandemic Sciences Institute, University of Oxford, Oxford, UK; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.…. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Genome, Viral. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NIHR, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Persistent SARS-CoV-2 infections in hospitalised immunocompromised individuals are known to facilitate accelerated within-host viral evolution, potentially contributing to the emergence of highly divergent variants. However, little is known about the evolutionary dynamics and transmission risks of persistent infections in the general population. We aimed to characterise the within-host evolution of SARS-CoV-2 during persistent infections identified through a large community surveillance study. METHODS: We used data from the Office for National Statistics COVID-19 Infection Survey (ONS-CIS), a large-scale, longitudinal, population-based surveillance study conducted in the UK from April, 2020, to March, 2023. For this analysis, we focused on infections with high viral load (cycle threshold ≤30) and available genome sequences, from seven major SARS-CoV-2 lineages (alpha, delta, BA.1, BA.2, BA.4, BA.5, and XBB). ONS-CIS participants were randomly selected from the general population and tested regularly by RT-PCR, regardless of symptoms. We defined persistent infections as those with sustained or rebounding high viral RNA titres for 26 days or longer. We examined associated host characteristics and used raw sequence data to identify de novo mutations and estimate within-host synonymous and non-synonymous evolutionary rates across the SARS-CoV-2 genome. FINDINGS: Between Nov 2, 2020, and March 21, 2023, we identified 576 persistent infections with at least two sequences, including 11 alpha, 106 delta, 102 BA.1, 204 BA.2, 16 BA.4, 133 BA.5, and 4 XBB. Persistent infections were more common in males than females (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2Genome, ViralHumansMaleFemaleUnited KingdomMiddle AgedLongitudinal StudiesAdultAgedEvolution, MolecularAdolescentYoung AdultViral LoadMutationChildGenetic VariationAged, 80 and over

Autor:innen und Institutionen

  • Pandemic Sciences Institute, University of Oxford, Oxford, UK; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. Electronic address: mahan.ghafari@ndm.ox.ac.uk.
  • Pandemic Sciences Institute, University of Oxford, Oxford, UK; Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Office for National Statistics, Newport, UK.
  • Nuffield Department of Medicine, University of Oxford, Oxford, UK; NIHR Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, UK; NIHR Oxfo…
  • Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; The Sydney Infectious Diseases Institute (Sydney ID), School of Medical Sciences, University of Sydney, Sydney, NSW, Australia.

Förderung

  • Wellcome Trust
  • NIHR
  • Medical Research Council
  • Department of Health
  • National Institute for Health and Care Research
  • Royal Society
  • Li Ka Shing Foundation
  • Department of Health and Social Care

Zitieren

APA

Ghafari, M., Kemp, S. A., Hall, M., Clarke, J., Ferretti, L., Thomson, L., Studley, R., COVID-19 Infection Survey Group, COVID-19 Genomics UK (COG-UK) Consortium, Walker, A. S., Golubchik, T., & Lythgoe, K. (2025). SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance study. The Lancet Microbe, 6(9), 101154. https://doi.org/10.1016/j.lanmic.2025.101154

Vancouver

Ghafari M, Kemp SA, Hall M, Clarke J, Ferretti L, Thomson L, et al. SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance study. The Lancet Microbe. 2025;6(9):101154. doi:10.1016/j.lanmic.2025.101154

BibTeX
@article{Ghafari2025,
  author = {Ghafari, Mahan and Kemp, Steven A and Hall, Matthew and Clarke, Joseph and Ferretti, Luca and Thomson, Laura and Studley, Ruth and COVID-19 Infection Survey Group, COVID-19 Infection Survey Group and COVID-19 Genomics UK (COG-UK) Consortium, COVID-19 Genomics UK (COG-UK) Consortium and Walker, Ann Sarah and Golubchik, Tanya and Lythgoe, Katrina},
  title = {SARS-CoV-2 genomic diversity and within-host evolution in individuals with persistent infection in the UK: an observational, longitudinal, population-based surveillance study},
  journal = {The Lancet Microbe},
  year = {2025},
  volume = {6},
  number = {9},
  pages = {101154},
  doi = {10.1016/j.lanmic.2025.101154}
}
Kostenlos starten →